ICUINasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
ICU MEDICAL INC/DE
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$161.24−1.75 (-1.07%)
Close on Oct 19, 2026
- Market cap
- $4.04B
- P/E (TTM)
- 134.4
- Dividend yield
- –
ICU MEDICAL INC/DE revenue by segment
By business segment
By product or service
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Infusion Consumables [Member] | $1.14B | $1.12B | $1.11B | $1.09B | $1.07B | $1.06B | $1.04B | $1.02B | $1.00B | $977.05M | $969.13M | $957.35M | 52.7% | +6.1% |
| Infusion Systems [Member] | $718.81M | $697.51M | $684.21M | $679.57M | $665.43M | $661.37M | $652.41M | $645.95M | $635.16M | $624.67M | $629.04M | $632.85M | 33.3% | +8.0% |
| Vital Care | $303.47M | $338.09M | $437.92M | $548.21M | $634.70M | $697.67M | $690.77M | $669.39M | $667.23M | $655.42M | $660.95M | $659.09M | 14.1% | -52.2% |
By region
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $1.30B | $1.28B | $1.36B | $1.44B | $1.51B | $1.55B | $1.53B | $1.50B | $1.48B | $1.45B | $1.44B | $1.43B | 60.1% | -13.8% |
| EMEA [Member] | $416.68M | $420.67M | $411.68M | $407.96M | $394.58M | $390.83M | $393.53M | $391.99M | $378.29M | $372.97M | $373.57M | $368.92M | 19.3% | +5.6% |
| Other foreign countries [Member] | $216.06M | $220.95M | $230.56M | $233.55M | $233.88M | $234.69M | $223.59M | $214.98M | $207.61M | $202.25M | $203.84M | $202.53M | 10.0% | -7.6% |
From the segment and revenue-disaggregation notes of Icu Medical's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.